- Title: Subtitle
- Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia
- Creators
- Shukaib Arslan - City Of Hope National Medical CenterJianying Zhang - City Of Hope National Medical CenterPrajwal Dhakal - University of Nebraska Medical CenterJenna Moran - Massachusetts General HospitalNuthana Naidoo - University of Southern CaliforniaJennifer Lombardi - Massachusetts General HospitalVinod Pullarkat - City Of Hope National Medical CenterAnthony S. Stein - City Of Hope National Medical CenterGuido Marcucci - City Of Hope National Medical CenterGeorge Yaghmour - University of Southern CaliforniaVijaya R. Bhatt - University of Nebraska Medical CenterAmir T. Fathi - Massachusetts General HospitalIbrahim Aldoss - City Of Hope National Medical Center
- Resource Type
- Letter/Communication
- Publication Details
- American journal of hematology, Vol.96(3), pp.E59-E63
- Publisher
- Wiley
- DOI
- 10.1002/ajh.26057
- PMID
- 33227142
- ISSN
- 0361-8609
- eISSN
- 1096-8652
- Number of pages
- 5
- Language
- English
- Date published
- 03/01/2021
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984359949402771
Letter/Communication
Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia
American journal of hematology, Vol.96(3), pp.E59-E63
03/01/2021
DOI: 10.1002/ajh.26057
PMID: 33227142
Abstract
Details
Metrics
18 Record Views